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detrimental effect on hepatic regeneration was more
due to portal pooling and reperfusion of portal blood
than ischemia/reperfusion by itself.
One problem in the preoperative evaluation of
patients with liver cirrhosis is how to estimate the
amount of ischaemia that can be inflicted on the liver
with no harm. The patient group with liver cirrhosis
comprises a wide range of functional reserve in rela-
tion to operative tolerance to ischemia. This is particu-
larly difficult since we do not know which cell types in
the liver are more prone to hypoxia. One group of
patients which seems to be at particularly high risk for
morbidity is patients with cholestasis. In this group of
patients with cirrhosis and cholestasis preoperative
drainage prior to resection may be indicated.
In conclusion, patients with cirrhosis can undergo
hepatic resection with inflow occlusion with reduced
blood loss and thereby reduced morbidity without in-
flicting any significant ischaemic damage to the liver,
if ischaemia time is of one hour duration or less.
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IMPROVED RESULTS FOR RESECTION OF
PERIAMPULLARY ADENOCARCINOMA
ABSTRACT
Andersen, H.B., Baden, H., Brahe, N.E.B. and Burcharth, F. (1994) Pancreatico-
duodenectomy for periampullary adenocarcinoma Journal of the American College of
Surgeons 179." 545-552.
Background: This study evaluates the indications for and effects of pancreaticoduo-
denectomy (102 patients) or total pancreatectomy (15 patients) with extensive
lymph node dissection performed upon 117 patients for treatment of periampullary
adenocarcinoma.
Study Design: Presenting symptoms and postoperative morbidity and mortality rates
were recorded. Cumulative survival rates were evaluated in relation to origin, size, and
staging of tumor. Postoperative follow-up of clinical symptons was done after one year.
Results: The postoperative mortality rate after Whipple’s operation was 8 percent (eight
patients). The median survival period was 1.1 year and the overall five year survival rate126 HPB INTERNATIONAL
was 15 percent (confidence limits, 5 to 25 percent). Thefive year survival rate for patients
without tumor extension beyond the pancreas was 25 percent (confidence limits, 5 to 50
percent), and in patients with adenocarcinoma of the ampulla of Vater, 34 percent
(confidence limits, 3 to 65 percent). The median survival rate in patients with
adenocarcinoma of the ampulla of Vater was 3.3 years, which was significantly longer
than in the other patients. Fifty-nine patients with distant spread could be divided into 14
patients with para-aortic lymph node metastases who had a significantly shorter survival
period than 45 patients without para-aortic lymph node metastases (p=0.004). Most
patients surviving more than one year were doing well, although 60 percent needed
exocrine pancreatic substitution therapy.
Conclusions: Resection of periampullary carcinoma provides a better pallia-
tion and survival rate than nonoperative biliary drainage or bypass operation.
An improved preoperative verification of para-aortic metastases could restrict resection
to patients with a prognostic five year survival rate of more than 25 percent and a
postoperative mortality rate of less than 5 percent. J. Am. Coll. Surg., 1994,
179: 545-552.
KEY WORDS: Periampullary carcinoma
duodenectomy.
PAPER DISCUSSION
Resection of the pancreatic head and adjacent
structures offers the only hope for cure ofpatients with
adenocarcinoma of the periampullary region consist-
ing ofcancer ofthe pancreatic head, ampulla ofVater,
distal common bile duct and duodenum. Although
these tumours are frequently lumped together because
of their similar symptomatology and diagnostic
and therapeutic approach, the prognosis after resection
differs substantially as shown in the paper ofAnderson
and coauthors. Especially for adenocarcinoma of the
pancreatic head tumours, the possible benefit ofresec-
tion is small and the costs expressed as morbidity can
be substantial even though operative mortality ranges
from 0 to 8.9% in the last few years2-9. In fact this
operative mortality is even lower than after seemingly
less invasive surgical procedure such as gastric
resection for cancer1. The improved operative
mortality after pancreatoduodenectomy in experienced
hands has led to a more aggressive approach
although long term survival has not improved much
in patients surviving the resection
11 as compared to
the days when Crile advised strongly against Whipple’s
procedure for pancreatic head cancers2.
There is a strong correlation between surgical expe-
rience and operative risk 13,14. Centres with a volume of
more than eighty cases in an eight-year study period
had a mortality of 5.5% as compared with 12.9%
mortality in medium (51-80), 11.8% in low (10-50)
and 18.9% in minimal (<10) volume hospitals4. Ac-
cording to these criteria the data in the paper by
Pancre scarcinoma Pancreatico-
Andersen et al., come from a low to medium volume
hospital and the operative mortality of 12% is what
can be expected. The mortality in 102 of the 117
patients undergoing pancreato-duodenectomy is
8%, but additional portal vein resection and/or
total pancreatectomy led to a prohibitive high
operative mortality in those 15 patients. These data
should caution the authors, as well as other
pancreatectomists, to reconsider the necessity of ex-
tensive procedures since there is little evidence that
resections of major vessels such as the portal
or mesenteric vein improves the longterm survival
after pancreato-duodenectomy. However, when the
point ofno return is passed, tumour can be left behind
at the portal vein and a pancreato-duodenectomy
performed for palliation. This can be done with
low mortality and an acceptable quality of life 16.
Total pancreato-duodenectomy for cancer has been
abandoned by most surgeons because evidence that
this more extensive operation will improve survival is
lacking7. For practical reasons many surgeons re-
resect a part of the pancreatic remnant when frozen
section shows tumor residue at the pancreatic resec-
tion margin.
Even in one series with a zero operative
mortality after pancreato-duodenectomy, morbidity
was present in about half of the patients4. Leakage
of the pancreatico-enterotomy is one of the leading
causes of postoperative morbidity in 5 to 25% of
the patients in most series regardless of the type of
anastomosis
18 or whether a pancreaticojejunostomy
or pancreatico-gastrostomy is performed 19. Peri-HPB INTERNATIONAL 127
operative administration of Somatostatin has been
reported to lower the chance of this complication2.
Andersen et al. report anastomotic leakages at the
pancreato-jejunostomy site in 9 patients, leading to
postoperative death in 2 patients. A 25 % mortality
after leakage of a pancreatic anastomosis has been
reported by others 18. Although anastomotic leakage
even occurs in centres with a large volume and exten-
sive experience, mortality due to this complication can
be avoided by agressive postoperative monitoring,
usingmainly clinical signs and symptoms21.
Although preoperative obstructive jaundice is
a well known risk factor in pancreatic surgery22, and
although studies in experimental animals univocally
stress the beneficial effect of preoperative drainage on
immune status, endotoxaemia, kidney and liver func-
tion, wound healing and other parameters23’4’5, the
beneficial effect of preoperative biliary drainage in
man has not been shown in prospective randomized
trials. The possible complications of external or inter-
nal drainage may very well outweigh the possible bene-
fits ofthe procedure26’27. Andersen et al. report that 47
of 117 patients underwent pre-operative drainage but
they do not elucidate the indication for this procedure.
Their hypothesis that pre-operative biliary drainage
would cause a technically more demanding bilio-
digestive anastomosis has neither been substantiated
by the literature nor by our own experience.
It may well be that postoperative gastrointestinal
and intra-abdominal bleeding, mentioned in the study
by Andersen et al. were the result oferosion ofamajor
artery that is a well known complication ofpancreatic
and biliary surgery8. Andersen et al. show a tendency
to a higher postoperative morbidity and mortality
rate among patients who were older than seventy.
Although this age limit has been mentioned over the
years, more recent reports do not indicate any in-
creased risk for elderly patients selected for pancreatic
surgeryS,11,29o
Surgical techniques of pancreato-duodenectomy
for periampullary cancer have changed and unlike
Andersen et al., most authors favour the pylorus pre-
serving modification with equal results for survival
and possible benefits for weight gain and long
term gastrointestinal function3. Delayed gastric
emptying that has been reported after pylorus preserv-
ing pancreatoduodenectomy is only a transient phe-
nomenon and is probably more dependent on the
incidence of postoperative complications than on the
preservation of the pylorus per se31.
Andersen et al. perform what they called ’extensive
lymph node dissections’ during PD in this
series. According to one Japanese study extended
lymph node dissection could result in an improved
survival in patients with early stage tumours3, but
prospective studies of the effect oflymph node dissec-
tion have not been performed. Extensive dissection
around the coeliac axis may cause severe postopera-
tive diarrhoea and, according to our own experience,
postoperative septic bleeding probably occurs more
frequently after extended lymph node dissection.
Andersen et al. show that long term survival
was absent in patients with positive para-aortic lymph
nodes and that pancreatoduodenectomy was pallia-
tive in these patients. Therefore biopsy of pre-aortic
lymph nodes with frozen sections could have been
helpful in the therapeutic approach during explora-
tory laparotomy, unless pancreato-duodenectomy is
chosen as a palliative procedure. Although diagnostic
laparoscopy has proven to be helpful in preoperative
staging of pancreatic cancer
33 visualization and
biopsy of retropancreatic preaortic region are impossi-
ble through the laparoscope.
Survival after resection for periampullary adeno-
carcinoma in the paper by Andersen et al. is in
accordance with many other studies and our own
experience34. Although a five-year survival as high as
50% can be reached after resection for carcinoma of
the ampulla, the prognosis for other periampullary
tumours is poor and no improvement by the extended
lymph node dissection has been achieved in the paper
by Andersen et al. Adjuvant chemoradiotherapy can
be a potential benefit. 5FU with radiotherapy has been
shown to be beneficial in one prospective randomized
study3s. The results oftwo recent prospective trials are
awaited.
To conclude: early diagnosis, adequate preoperative
conditioning, good preoperative staging including di-
agnostic laparoscopy, and optimal surgical techniques
by an experienced surgeon in a high volume hospital,
are all we can offer to these patients to improve short
term survival and to lower postoperative morbidity.
Whether extended lymph node dissection and
perioperative chemotherapy and radiotherapy are
beneficial for long term survival should be the subject
of further clinical studies.
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